NCT06621472 2026-03-18
Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery
Cairo University
Phase NA Recruiting
Clinical Trials
354 trialsNCT07010497 2026-03-18
IAPETUS
Asan Medical Center
Phase 2 Recruiting
NCT05468359 2026-03-16
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
St. Jude Children's Research Hospital
Phase 1/2 Recruiting
NCT05528952 2026-03-16
TERTIO
Centre Hospitalier Universitaire de Besancon
Phase 2 Recruiting
NCT06796114 2026-03-16
PREDICT-HCC
Centre Hospitalier Universitaire de Besancon
Phase NA Recruiting
NCT05901519 2026-03-13
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Recruiting
NCT07469319 2026-03-13
BISHOP
University of Aarhus
Phase NA Recruiting
NCT05095714 2026-03-12
FASTRAK
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT05269381 2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2 Recruiting
NCT06349642 2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
NCT06537193 2026-03-10
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
Asan Medical Center
Phase NA Recruiting
NCT04792463 2026-03-09
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
Recruiting
NCT04380545 2026-03-06
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT06885879 2026-03-04
Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
Chinese University of Hong Kong
Recruiting
NCT07295275 2026-03-03
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
West China Hospital
Recruiting
NCT06789848 2026-02-27
Ligufalimab and Cadonilimab in Advanced Liver Cancers
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT07436845 2026-02-27
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
Nanfang Hospital, Southern Medical University
Recruiting
NCT03942328 2026-02-24
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Mayo Clinic
Phase 1/2 Recruiting
NCT04134559 2026-02-24
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT05497531 2026-02-24
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
University of California, Irvine
Phase NA Recruiting
NCT06944483 2026-02-24
ISTAR-01
Seoul National University Hospital
Recruiting
NCT07429864 2026-02-24
Bio-Delta
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT07428356 2026-02-23
HALT
National Cancer Centre, Singapore
Phase NA Recruiting
NCT05488522 2026-02-20
SBRT With Atezo/Bev for HCC
Abramson Cancer Center at Penn Medicine
Phase 1 Recruiting
NCT07116486 2026-02-19
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04522544 2026-02-18
Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Recruiting
NCT05669339 2026-02-18
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
University of Florida
Phase 2 Recruiting
NCT07410494 2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2 Recruiting
NCT07417397 2026-02-18
Adjuvant TACE in HCC With High-risk Recurrence Factors
Guangxi Medical University
Phase 3 Recruiting
NCT07148050 2026-02-17
IMPACT
Seattle Children's Hospital
Phase 1 Recruiting
NCT07413354 2026-02-17
Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma
Tongji Hospital
Phase 2 Recruiting
NCT05128890 2026-02-11
Evaluation of Resection Techniques for Pancreatic Tumors
Methodist Health System
Recruiting
NCT07395635 2026-02-09
Phase II Trial of Immunonutrition in Hepatectomy
Tata Memorial Centre
Phase NA Recruiting
NCT05375370 2026-02-06
REMNANT
University Hospital, Rouen
Phase NA Recruiting
NCT07391839 2026-02-06
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Suzhou Mednovo Yi Medical Technology Co., Ltd.
Phase 1 Recruiting
NCT07365930 2026-02-05
NISTIPS
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting
NCT07378709 2026-02-05
BLOOD-TACE-P
University of Belgrade
Recruiting
NCT06904170 2026-02-03
ALICE
UNICANCER
Phase 2/3 Recruiting
NCT07178587 2026-02-03
ELMIRA
Nantes University Hospital
Phase NA Recruiting
NCT05791448 2026-02-02
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
University of Southern California
Phase 1 Recruiting
NCT07312162 2026-01-30
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
University of Southern California
Recruiting
NCT06553885 2026-01-29
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
NCT07345247 2026-01-22
RASEREM
Ankara University
Recruiting
NCT07359586 2026-01-22
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Zhejiang University
Recruiting
NCT05155189 2026-01-21
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
Zhejiang University
Phase 1 Recruiting
NCT07331883 2026-01-21
Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)
Ruijin Hospital
Phase 2 Recruiting
NCT07324824 2026-01-16
Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2 Recruiting
NCT06405321 2026-01-14
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Guangxi Medical University
Recruiting
NCT07337421 2026-01-13
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
Northern Jiangsu People's Hospital
Phase 2 Recruiting
NCT07337460 2026-01-13
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
Northern Jiangsu People's Hospital
Phase 2 Recruiting